Home > Boards > Free Zone > User's Groups > SMART MONEY GROUP

TNXP > Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
crudeoil24 Member Profile
Member Level 
Followed By 542
Posts 35,054
Boards Moderated 5
Alias Born 12/12/04
160x600 placeholder
crudeoil24 Member Level  Thursday, 05/23/19 07:39:07 AM
Re: None
Post # of 108792 
TNXP > Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company focused on developing small molecules and biologics to treat psychiatric, pain and addiction conditions as well as to improve biodefense, announced today that it has in-licensed a Phase 2 asset, TNX-1300 (T172R/G173Q double-mutant cocaine esterase 200 mg, i.v. solution)* for the treatment of cocaine intoxication. TNX-1300 is designated as a breakthrough therapy by the U.S. Food and Drug Administration (FDA).

New York Yankees and Duke Basketball
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist